ORION CORPORATION STOCK EXCHANGE RELEASE
Successor plan of the President and CEO of Orion
According to the agreement on the position of President and CEO of
The Board of Directors of Orion and
It is the intention of the parties that the successor of
The Board of Directors has started a recruitment process for the successor of President and CEO.
Mikael Silvennoinen Olli Huotari
Chairman of the Board of Directors Senior Vice President, Corporate Functions
Contact person:
Chairman of the Board of Directors
tel: +358 501 537
Publisher:
Communications
Orionintie 1A, FI-02200 Espoo,
www.orion.fi
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2020 amounted to
© OMX, source